Division of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Eur J Cardiothorac Surg. 2010 Jul;38(1):27-33. doi: 10.1016/j.ejcts.2010.01.017. Epub 2010 Feb 26.
The increasing age of the population has raised the importance of determining the minimally required surgical treatment for elderly lung cancer patients. Despite a number of previous studies, the therapeutic impact of a radical mediastinal lymphadenectomy (RLA) associated with a pulmonary resection for lung cancer remains controversial. Herein, we investigated the impact of lymph node dissection on the overall survival for elderly lung cancer patients and assessed whether the non-performance of an RLA could be justified in the surgical treatment for these elderly patients.
We analysed the data for 160 patients aged 70 years and older (113 males, 47 females) who underwent curative-intent surgery for non-small-cell lung cancer. They were divided into two groups, according to the method used for the intra-operative mediastinal lymph node dissection, the radical systematic lymphadenectomy (RLA, n=76) and the non-radical lymphadenectomy (NLA, n=94) groups. A Cox proportional hazards model and the Kaplan-Meier method were used for the survival analyses. Propensity-based analyses were also used to reduce the effect of non-randomisation and possible bias in indication of treatment between the two groups.
RLAs had no protective effect on mortality; the hazard ratio for the RLA group in comparison to the NLA group was 0.97 (95% confidence interval (CI): 0.32-2.89) in the multivariate analysis and 1.43 (95% CI: 0.42-4.91) in the propensity-based stratifying analysis. The 3-year survival probability was 81.3% (95% CI: 67.1-89.8) for the NLA group, which was marginally better than that of the RLA group (77.5% (95% CI: 63.3-86.8)). There was no significant difference in the overall survival between the two groups (p=0.26). The 3-year survival probability of the NLA group at each quartile of the propensity score also tended to be better than that of the RLA group, which did not show any significant difference.
There was no survival benefit shown for RLA associated with pulmonary resections in the present cohort, even in the propensity-based analyses. Although some reports recommend a systematic mediastinal lymphadenectomy for proper staging and better survival, a pulmonary resection with non-performance of radical lymphadenectomy could be an acceptable surgical treatment for the increasing number of elderly lung cancer patients.
人口老龄化增加了确定老年肺癌患者最小手术治疗的重要性。尽管有许多先前的研究,但肺癌根治性纵隔淋巴结清扫术(RLA)与肺切除术的治疗效果仍存在争议。在此,我们研究了淋巴结清扫对老年肺癌患者总生存的影响,并评估了在这些老年患者的手术治疗中不进行 RLA 是否合理。
我们分析了 160 名年龄在 70 岁及以上(男性 113 名,女性 47 名)接受非小细胞肺癌根治性手术的患者的数据。根据术中纵隔淋巴结清扫的方法将他们分为两组,即根治性系统性淋巴结清扫(RLA,n=76)和非根治性淋巴结清扫(NLA,n=94)组。采用 Cox 比例风险模型和 Kaplan-Meier 法进行生存分析。还采用倾向评分分析来减少两组之间治疗非随机化和指征可能存在的偏倚的影响。
RLA 对死亡率没有保护作用;多变量分析中,与 NLA 组相比,RLA 组的风险比为 0.97(95%置信区间(CI):0.32-2.89),倾向评分分层分析中为 1.43(95%CI:0.42-4.91)。NLA 组的 3 年生存率为 81.3%(95%CI:67.1-89.8),略高于 RLA 组(77.5%(95%CI:63.3-86.8))。两组之间总生存无显著差异(p=0.26)。在倾向评分的每个四分位点,NLA 组的 3 年生存率也趋于优于 RLA 组,但无显著差异。
本队列中,与肺切除术相关的 RLA 并未显示出生存获益,即使在倾向评分分析中也是如此。尽管一些报告建议进行系统性纵隔淋巴结清扫以进行适当分期和提高生存率,但对于越来越多的老年肺癌患者,不进行根治性淋巴结清扫的肺切除术可能是一种可接受的手术治疗方法。